HectorAlejandroArangoMD
Obstetrics & Gynecology • Clearwater, FLGynecologic Oncology
Assistant Clinical Professor of Obstetrics & Gynecology, University S Fla College of Medicine
Dr. Arango is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 Pinellas St
Ste 400
Clearwater, FL 33756Phone+1 813-302-8300Fax+1 727-447-2131
Education & Training
University of South Florida MorsaniResidency, Obstetrics and Gynecology, 1990 - 1994- University of South Florida College of MedicineClass of 1990
Certifications & Licensure
FL State Medical License 1991 - 2026- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
- Top Doctors: Florida Castle Connolly, 2000
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer Start of enrollment: 2005 Mar 21
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
- Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer Start of enrollment: 2009 Sep 14
Publications & Presentations
PubMed
- 261 citationsLysophospholipids are potential biomarkers of ovarian cancer.Rebecca Sutphen, Yan Xu, George D. Wilbanks, James V. Fiorica, Edward C. Grendys
Cancer Epidemiology, Biomarkers & Prevention. 2004-07-01 - 542 citationsBRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma casesTuya Pal, Jenny Permuth-Wey, A R N Judith Betts, Jeffrey P. Krischer, James Fiorica
Cancer. 2005-12-15 - 276 citationsA genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24Ellen L. Goode, Georgia Chenevix-Trench, Honglin Song, Susan J. Ramus, Maria Notaridou
Nature Genetics. 2010-10-01
Press Mentions
Arango Joins BayCare Medical GroupNovember 10th, 2016
King Engineering Gets New Vice PresidentNovember 4th, 2016
Professional Memberships
- Member
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
